Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Method of optimizing the treatment of Philadelphia-positive leukemia with imatinib mesylate

US Patent 8697702 · Granted Apr 15, 2014

Estimated economic value: $13,775,000

Assignee

Inventors

View full patent text on Google Patents →